Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» atypical hemolytic uremic syndrome
atypical hemolytic uremic syndrome
FDA fast-tracks Alexion's Ultomiris in 2nd Soliris indication
Fierce Pharma
Fri, 06/21/19 - 11:40 pm
Alexion
Ultomiris
FDA
atypical hemolytic uremic syndrome
Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)
Yahoo/BusinessWire
Sat, 11/9/13 - 12:29 pm
Soliris
atypical hemolytic uremic syndrome
Alexion
Alexion's Soliris receives marketing approval in Japan
The Fly on the Wall
Fri, 09/13/13 - 09:09 am
Japan
Soliris
Alexion
atypical hemolytic uremic syndrome
Alexion Pharma on a High
Yahoo/Zacks.com
Mon, 09/26/11 - 11:12 am
Alexion
Soliris
aHUS
atypical hemolytic uremic syndrome
Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Benzinga
Sun, 06/12/11 - 11:09 am
Soliris
Alexion
atypical hemolytic uremic syndrome
Positive Data on Alexion's Soliris
Yahoo/Zacks.com
Tue, 11/23/10 - 10:05 pm
Soliris
Alexion
aHUS
atypical hemolytic uremic syndrome